Fortress Biotech, Inc. (FBIO)
NASDAQ: FBIO · Real-Time Price · USD
1.720
-0.020 (-1.15%)
Dec 20, 2024, 4:00 PM EST - Market closed
Fortress Biotech Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
Operating Revenue | 62.5 | 64.99 | 73.07 | 68.79 | 45.6 | 36.63 | Upgrade
|
Other Revenue | 19 | 19.52 | 2.67 | - | - | - | Upgrade
|
Revenue | 81.5 | 84.51 | 75.74 | 68.79 | 45.6 | 36.63 | Upgrade
|
Revenue Growth (YoY) | 31.51% | 11.58% | 10.11% | 50.86% | 24.49% | 36.26% | Upgrade
|
Cost of Revenue | 85.67 | 132.73 | 165.65 | 160.95 | 78.7 | 10.53 | Upgrade
|
Gross Profit | -4.17 | -48.22 | -89.91 | -92.16 | -33.1 | 26.1 | Upgrade
|
Selling, General & Admin | 80.34 | 90.98 | 113.66 | 86.84 | 61.17 | 55.59 | Upgrade
|
Research & Development | - | - | - | - | - | 81.33 | Upgrade
|
Operating Expenses | 80.34 | 90.98 | 113.66 | 86.84 | 61.17 | 136.92 | Upgrade
|
Operating Income | -84.51 | -139.2 | -203.56 | -179 | -94.27 | -110.82 | Upgrade
|
Interest Expense | -9.41 | -15.32 | -13.64 | -15.31 | -15.33 | -11.85 | Upgrade
|
Interest & Investment Income | 2.86 | 3 | 1.4 | 0.65 | 1.52 | 2.56 | Upgrade
|
Other Non Operating Income (Expenses) | -10.73 | 1.02 | 2.34 | -0.45 | -1.19 | -0.03 | Upgrade
|
EBT Excluding Unusual Items | -101.79 | -150.49 | -213.46 | -194.11 | -109.27 | -120.14 | Upgrade
|
Gain (Loss) on Sale of Investments | - | - | - | 39.29 | 6.42 | - | Upgrade
|
Gain (Loss) on Sale of Assets | 2.75 | - | - | - | - | 18.48 | Upgrade
|
Asset Writedown | -2.65 | -3.14 | - | - | - | - | Upgrade
|
Other Unusual Items | -21.48 | - | - | -9.54 | - | - | Upgrade
|
Pretax Income | -123.17 | -153.63 | -213.46 | -164.35 | -102.85 | -101.66 | Upgrade
|
Income Tax Expense | 0.36 | 0.52 | 0.45 | 0.47 | 0.14 | - | Upgrade
|
Earnings From Continuing Operations | -123.52 | -154.15 | -213.91 | -164.83 | -102.99 | -101.66 | Upgrade
|
Net Income to Company | -123.52 | -154.15 | -213.91 | -164.83 | -102.99 | -101.66 | Upgrade
|
Minority Interest in Earnings | 75.01 | 93.52 | 127.34 | 100.12 | 56.46 | 61.7 | Upgrade
|
Net Income | -48.51 | -60.64 | -86.58 | -64.7 | -46.53 | -39.96 | Upgrade
|
Preferred Dividends & Other Adjustments | 9.01 | 8.03 | 8.03 | - | - | - | Upgrade
|
Net Income to Common | -57.53 | -68.67 | -94.61 | -64.7 | -46.53 | -39.96 | Upgrade
|
Shares Outstanding (Basic) | 17 | 8 | 6 | 5 | 5 | 4 | Upgrade
|
Shares Outstanding (Diluted) | 17 | 8 | 6 | 5 | 5 | 4 | Upgrade
|
Shares Change (YoY) | 144.73% | 36.89% | 8.78% | 13.46% | 31.61% | 25.88% | Upgrade
|
EPS (Basic) | -3.39 | -8.47 | -15.97 | -11.88 | -9.69 | -10.96 | Upgrade
|
EPS (Diluted) | -3.39 | -8.47 | -15.97 | -11.88 | -9.69 | -10.96 | Upgrade
|
Free Cash Flow | -102.25 | -128.29 | -182.12 | -121.11 | -85.61 | -97.31 | Upgrade
|
Free Cash Flow Per Share | -6.03 | -15.82 | -30.74 | -22.23 | -17.83 | -26.68 | Upgrade
|
Gross Margin | -5.12% | -57.05% | -118.70% | -133.97% | -72.60% | 71.25% | Upgrade
|
Operating Margin | -103.69% | -164.71% | -268.76% | -260.21% | -206.74% | -302.54% | Upgrade
|
Profit Margin | -70.58% | -81.25% | -124.91% | -94.06% | -102.03% | -109.09% | Upgrade
|
Free Cash Flow Margin | -125.45% | -151.80% | -240.44% | -176.05% | -187.74% | -265.65% | Upgrade
|
EBITDA | -79.98 | -133.2 | -196.18 | -173.9 | -90.57 | -107.72 | Upgrade
|
EBITDA Margin | -98.13% | -157.61% | -259.00% | -252.79% | -198.62% | -294.09% | Upgrade
|
D&A For EBITDA | 4.53 | 6 | 7.39 | 5.1 | 3.7 | 3.1 | Upgrade
|
EBIT | -84.51 | -139.2 | -203.56 | -179 | -94.27 | -110.82 | Upgrade
|
EBIT Margin | -103.69% | -164.71% | -268.76% | -260.21% | -206.74% | - | Upgrade
|
Revenue as Reported | 62.5 | 84.51 | 75.74 | 68.79 | 45.6 | 36.63 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.